Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | TVTX | CRSP | ||
| Company | Eidos Therapeutics Inc | Travere Therapeutics Inc | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 57.29 | 48.54 | ||
| High | 128.49 | 57.55 | 49.03 | ||
| Low | 116.83 | 55.30 | 47.31 | ||
| Last | 122.21 | 55.89 | 47.99 | ||
| Change | -6.23 | -1.39 | -0.45 | ||
| Percent Change | -4.85% | -2.43% | -0.93% | ||
| Volume | 335,500 | 1,715,000 | 1,036,200 | ||
| 20-Day Average Volume | 113,985 | 1,258,340 | 1,672,965 | ||
| Previous | 128.44 | 57.28 | 48.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 56.72 | 50.76 | ||
| 20-Day Raw Stochastic | 36.63% | 41.29% | 11.96% | ||
| 20-Day Relative Strength | 56.42 | 54.77 | 43.32 | ||
| Weighted Alpha | +136.62 | +164.66 | -18.38 | ||
| Today's Opinion | 88% Buy | 88% Buy | 88% Sell | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | -2.56% since 07/24/26 | +3.12% since 07/24/26 | ||
| Low | 116.83 on 01/25/21 | 54.59 on 07/29/26 | 45.89 on 07/28/26 | ||
| High | 131.08 on 01/20/21 | 59.09 on 07/27/26 | 49.03 on 07/31/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | -1.62% since 06/30/26 | -12.01% since 06/30/26 | ||
| Low | 116.24 on 01/05/21 | 53.00 on 07/17/26 | 45.89 on 07/28/26 | ||
| High | 132.54 on 01/04/21 | 60.00 on 07/23/26 | 63.45 on 07/06/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +32.69% since 04/30/26 | -8.31% since 04/30/26 | ||
| Low | 69.38 on 10/30/20 | 41.32 on 05/19/26 | 45.89 on 07/28/26 | ||
| High | 132.54 on 01/04/21 | 60.10 on 06/25/26 | 63.45 on 07/06/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +79.77% since 01/30/26 | -3.94% since 01/30/26 | ||
| Low | 38.44 on 07/31/20 | 26.15 on 03/20/26 | 44.12 on 03/30/26 | ||
| High | 132.54 on 01/04/21 | 60.10 on 06/25/26 | 63.45 on 07/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 5,197,378 | 4,628,587 | ||
| Shares Outstanding, K | 38,873 | 92,993 | 96,449 | ||
| Annual Sales, $M | 26,690,000 | 490,730,000 | 3,510,000 | ||
| Annual Net Income, $M | -37,840,000 | -25,550,000 | -581,600,000 | ||
| Last Qtr Sales, $M | 130,000 | 127,200,000 | 1,460,000 | ||
| Last Qtr Income, $M | -30,180,000 | -37,100,000 | -122,930,000 | ||
| 60-Month Beta | -0.16 | 1.10 | 1.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.39 on 05/04/26 | -1.28 on 05/04/26 | ||
| Latest Earnings Date | 02/24/21 | 08/04/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||